Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05843526
Other study ID # B707201628072
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date May 1, 2019
Est. completion date October 1, 2022

Study information

Verified date April 2023
Source University of Liege
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of this study was to characterize the host-related response of peri-implant soft tissue induced by 3 different materials: titanium, resin and PEEK (polyetheretherketone) on man. The primary endpoint is to asses the histological data available: Histological analyses are carried out with immunohistology (CD68, CD3, CD20, macrophages), non decalcified histology to appreciate the structure of the peri implant soft tissues (Sulcus depth, junctional epithelium, connective tissue adhesion). Moreover: scanning electronic microscope (SEM) of the experimental abutment is performed to juge the cell adhesion on the abutment surface. The secondary endpoint is to assess clinical data, radiological bone remodeling regarding the different material. The hypothesis is that resin abutment lead to more inflammation than PEEK or titanium.


Description:

The present study was designed as a randomized controlled trial. A total of 69 implants were placed and experimental abutments made of grade 5 titanium (Ti), dental resin (Optibond ™ FL, Kerr Dental)), polyetheretherketone (PEEK) were randomly allocated to each implant. Study population: Patients needing tooth replacement in the posterior region (molars) are recruited from the Department of Periodontology and Oral and Implant Surgery of the University of Liege, Belgium. Procedures After a local anesthesia, implant procedure is carried out according to the recommendation of the manufacturer while considering the future position of the crown for a screw-retained restoration and the bone anatomy. Then, implants (Bone level or Bone level tapered, SLA active, Straumann Group, Basel, Switzerland) are placed with an insertion torque of at least 20 N/cm. The experimental abutment material is randomly allocated to the implant or two implants when it is possible: Titanium as a group control, PEEK (polyetheretherketone) or resin abutment. The insertion is made at 15 N/cm and the access hole is obturated with teflon and Telio (Ivoclar vivadent, Schaan, Liechtenstein). A standardized parallel peri-apical radiograph is taken in order to record the baseline bone level. Each patient is instructed to rinse twice daily with an aqueous solution of 0,2% Chlorhexidine (Corsodyl®, GSK, Brentford, United Kingdom) and to avoid brushing of the area until the first recall 10-12 days later. Anti-inflammatories (Ibuprofen® 600 mg) as well as additional analgesics (Paracetamol® 500 mg) are recommended according to the patient's needs. Eight weeks after implantation, the buccal part of the abutment is marked with a drill, and a harvesting guide is placed on the experimental abutment. A punch device cut the soft tissue at 1mm from the abutment surface and both soft tissues and abutment are removed together. When the adherence between soft tissues and abutment is weak (soft tissues slide from the abutment), the abutment is analyzed alone on scanning electronic microscopy and the soft tissues alone are analyzed with immunohistochemistry. When adherence between the abutment and the soft tissues is sufficient, it goes to non decalcified histology. A screw retained abutment or a conventional healing abutment is placed after the harvesting procedure and the prosthetic rehabilitation is performed after 3 months of healing. Follow-up evaluations and data recording are performed at inclusion visit (baseline), surgery and 8 weeks after implantation.


Recruitment information / eligibility

Status Completed
Enrollment 68
Est. completion date October 1, 2022
Est. primary completion date May 1, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Needing implant therapy - One or more missing teeth in the posterior area of either maxilla or mandible - Good systemic health (ASA I/II) - Full mouth plaque score (FMPI) lower than or equal to 25% - The tooth at the implant site(s) had to be extracted or lost at least 12 weeks prior to implant placement - 3 mm of keratinized mucosa in the bucco-lingual dimension with bone crest allowing at least a regular diameter implant (4.1 mm). Exclusion Criteria: - Autoimmune disease requiring medical treatment - Medical conditions requiring prolonged use of steroids, use of bisphosphonates and denosumab intravenously or in oral use - Pregnancy or breastfeeding women - Alcoholism o chronical drug abuse - Immunocompromised patients - Uncontrolled diabetes - Smokers (more than 5 cigs/day) - Implant diameter under 4 mm (narrow implant) - Infection (systemic or local) - The site was excluded if it was previously treated with socket preservation techniques, presented untreated local inflammation, mucosal diseases or oral lesions, history of local irradiation therapy or persistent intraoral infection.

Study Design


Intervention

Device:
Experimental healing abutment
Implant placement (Straumann) Experimental abutment made of titanium, PEEK polyetheretherketone, resin was randomly assessed to the implant site. Abutment screw channel was filled with Teflon and closed with resin composite. Mouthwash based 0.2% chlorhexidine for 10 days and analgesics (ibuprofen 400 mg, up to 4/d) if necessary. After 8 weeks, harvesting of the soft tissues around experimental abutment with experimental abutment using a custom-made guide was placed on the experimental abutment

Locations

Country Name City State
Belgium Hospital University of Liège (CHU-Ulg) Liège

Sponsors (2)

Lead Sponsor Collaborator
University of Liege ITI International Team for Implantology, Switzerland

Country where clinical trial is conducted

Belgium, 

Outcome

Type Measure Description Time frame Safety issue
Primary Soft tissue inflammatory response To evaluate the inflammatory response of the peri-implant soft tissue after 8 weeks in contact with the abutment material: Immunohistological analysis of the quantity of macrophages, neutrophils, B and T lymphocytes and blood vessels present in the different samples.
It has been evaluated using markers: CD3, CD20, CD68, CD34 and counting of marked cells.
Data are reported with semi quantitative scale.
8 weeks
Primary Characterization of peri implant soft tissues To determine the composition and the length of different parts of the peri implant soft tissues depending on subgingival abutment material (regarding the data of sulcus depth, junctional epithelium and connective tissue in mm) using non decalcified histology. 8 weeks
Secondary dental plaque accumulation To assess the amount of plaque present on the abutments with SEM analysis. semi quantitative analyses are performed on the abutment. 8 weeks
Secondary Peri-implant bone remodeling Assessment of bone height changes using X-rays Radiographies are analyzed with software ImageJ and mesial and distal values of the bone remodeling (bone line to the implant shoulder) are collected in mm. 8 weeks
Secondary Soft tissue health changes assessed by Plaque Index Assessment of plaque percentage 8 weeks
Secondary Soft tissue health changes assessed by Keratinized gingiva measure Assessment of height of keratinized mucosa by probing in mm. 8 weeks
Secondary Soft tissue health changes assessed by soft tissues height Assessment of height of soft tissue by probing in mm. 8 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT05466006 - Peri-implant Soft Tissue Volume Changes at Small Buccal Dehiscences N/A
Withdrawn NCT00313989 - Evaluation of Osseo-integration After Placement of Dental Implants With Patients Receiving Radiotherapy for Buccopharyngeal Oncology N/A
Completed NCT05081050 - Short Implants Supporting Single Crowns in the Posterior Region
Completed NCT04707677 - Comparative Aesthetic Analysis Between Titanium and Ceramic Implants N/A
Recruiting NCT05989061 - PEEK Versus Titanium Customized Healing Abutments N/A
Recruiting NCT05722041 - Soft Tissue Volume Changes in Posterior Socket Sealing Abutment.
Completed NCT05512845 - The Double Factor Technique: a Computer-guided Implant Surgery Technique for Fully Edentulous Patients
Recruiting NCT03837158 - Titanium Zirconium (TiZr) Mini Implants N/A
Completed NCT01944267 - Procedures for Improving the Mucosa Around Implants N/A
Completed NCT00971516 - Healing Profile of Titanium Dental Implants Placed in Patients With Diabetes N/A
Completed NCT04305080 - Effect of Anodic Oxidation of Implant Abutment Collar on the Peri-implant Soft Tissue Health N/A
Completed NCT06191510 - Xenogenic Bone Intentionally Left Exposed
Completed NCT04459494 - In the Treatment of Implants With Different Methods; Early Bone Loss and Patient Satisfaction N/A
Recruiting NCT05644470 - Association of Implant Position and Crown Contour With Tissue Health
Completed NCT05101954 - Platelet Rich Fibrin and Concentrated Growth Factors on Osseointegration of Immediate Implants N/A
Recruiting NCT05748379 - Atraumatic Zirconia Abutment Versus Customized Composite Healing Abutment in Maxilla or Mandible. N/A
Recruiting NCT05627037 - Marginal Bone Level Around Titanium Implants Produced by Additive Manufacture N/A
Enrolling by invitation NCT06187805 - Retrospective Case Series - OSSIX Volumax Collagen Xenograft Scaffolding
Recruiting NCT06100120 - A Triple-blinded Non-inferiority Multicentre Randomized Controlled Trial Comparing Hybrid and Fully Etched Implants P1 N/A
Recruiting NCT06155799 - Accuracy of Dynamic Navigation System on Zygomatic Implant Placement N/A